Results 241 to 250 of about 9,433 (299)

Evaluating the corporate social responsibility agenda for high-cost novel therapies: roles for government and civil society. [PDF]

Health Res Policy Syst
Wong A, Saeed G, Garner S, Kohler J.
europepmc   +1 more source

Blockchain‐Based Smart Contracts in US Specialty Crop Marketing: Grower Preferences and Adoption Potential

Agribusiness, EarlyView.
ABSTRACT Using survey and discrete choice experiment data, we examined US specialty crop growers' preferences for marketing contract attributes in the context of emerging blockchain‐based technologies and expanding traceability initiatives. Results show that farmers preferred traditional written contracts but might be willing to accept digital ...
Elizabeth Canales, Alba J. Collart, Matthew G. Interis, Esther Mmenaa Agyemang‐Duah   +3 more
wiley   +1 more source

Win-Win Pricing of Follow-Up Policies Under Healthcare Warranties for Chronic Diseases: A Mathematical Modeling Approach. [PDF]

Healthcare (Basel)
Li M, Liu Z, Liang L.
europepmc   +1 more source

Challenges and enablers in fluidization technology

AIChE Journal, EarlyView.
Abstract Gas–solid fluidized beds provide excellent heat and mass transfer for high‐throughput operations from coating to catalytic conversion and underpin emerging low‐carbon technologies. Yet industrial reliability, scale‐up, and control lag scientific understanding, particularly as finer, stickier, and more variable feedstocks increasingly challenge
J. Ruud van Ommen, Jia Wei Chew
wiley   +1 more source

A practical electrodialysis model for accelerating system development

AIChE Journal, EarlyView.
Abstract Empirical optimization of electrodialysis (ED) is dependent on repetitive experiments with incremental adjustments, which is cost prohibitive at scale. While models can reduce the costs associated with optimization and scale‐up, existing ED models are limited in application to specific use cases and tend to be developed for the exploration of ...
Smith Pittman, Douglas Fankell, Jason C. Quinn, Kenneth F. Reardon   +3 more
wiley   +1 more source

Advancing diagnostics for Chagas disease: key product characteristics and harmonized evaluation strategies - an expert meeting report. [PDF]

BMC Infect Dis
Bohorquez LC, Schijman AG, Perez F, Coto H, Marchiol A, Pinazo MJ.   +5 more
europepmc   +1 more source

Cost-effectiveness of tarlatamab versus chemotherapy for patients with small-cell lung cancer after platinum-based chemotherapy in the United States and China. [PDF]

Front Pharmacol
Liu X, Wu Q, Li Q, Qin Y.
europepmc   +1 more source

Beyond hematopoietic stem cell transplantation: positioning Africa for scalable uptake of innovative sickle cell therapies. [PDF]

BMJ Glob Health
Agu CB, Abdulkareem R, Ajah CM, Ogunniyi TJ, Ndubisi AC.   +4 more
europepmc   +1 more source

Building material price data for predictive cost estimation in construction. [PDF]

Data Brief
Olowe OT, Adebiyi A, Obagbuwa IC.
europepmc   +1 more source

Patient-Derived Intestinal Organoids in the Global Cystic Fibrosis Landscape. [PDF]

Pediatr Pulmonol
Kroes S, Taylor-Cousar JL, Zampoli M, Karadag B, van der Ent CK, de Winter-de Groot KM, Beekman JM, Spelier S.   +7 more
europepmc   +1 more source